Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00022363
DRKS00022363
Completed
未知

Role of PSMA-PET/MRI for diagnosis and follow-up of focal therapy of prostate cancer - PSMA-FOXPRO

niversitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie0 sites15 target enrollmentJuly 13, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC61Malignant neoplasm of prostate

Overview

Phase
未知
Intervention
Not specified
Conditions
C61
Sponsor
niversitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie
Enrollment
15
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 13, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie

Eligibility Criteria

Inclusion Criteria

  • •Biopsy proven prostate cancer
  • •\- Serum PSA\-level \< 10ng/ml
  • •\- Gleason Score \= 3 \+ 4

Exclusion Criteria

  • •\- mpMRI or PET contraindications
  • •\- contrast agent allergy
  • •\- Pacemaker, neurostimulator, insulin pump
  • •\- shards of metal
  • •\- dental implants
  • •\- other implants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early StageProstate Cancer
NCT04116086Sheba Medical Center50
Completed
Not Applicable
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate CancerProstate Cancer
NCT02825875Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins200
Active, not recruiting
Phase 1
Evaluation of PSMA-PET and mpMRI in high-risk prostate cancer – using histopathologic validatioProstate cancerMedDRA version: 20.0Level: PTClassification code: 10060862Term: Prostate cancer Class: 100000004864Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]Therapeutic area: Diseases [C] - Neoplasms [C04]Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]
CTIS2022-501892-14-00Region Vasterbotten20
Recruiting
Not Applicable
The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate CancerProstate CancerPSMAp2PSA
NCT05822726Ruijin Hospital240
Recruiting
Early Phase 1
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active SurveillanceProstate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8
NCT05852041Northwestern University40